— Ticker · NYQ —
MRK · Merck & Co., Inc.
Healthcare · Drug Manufacturers - General
MRK
$119.72
▲ +5.56%
7-day move
7-day move
day$119.41 → $123.1152-wk$75.40 → $125.14avg vol9.6M / 3Mcap$295.7B
Plate I.
The Past Year, in One Line
The Valuation
| P/E (forward) | 12.6 |
| P/E (trailing) | 33.7 |
| EPS (forward) | $9.53 |
| EPS (trailing) | $3.55 |
| PEG | 5.69 |
| Dividend | 2.78% |
The Risk
| Beta | 0.20 |
| Short % float | 1.06% |
| Float | 2.47B |
| Shares out | 2.47B |
| Avg vol (3M) | 9.6M |
| 52w range | $75.40 → $125.14 |
The Analyst Tape
strong buybuyholdunderperformsell
$129.74
avg 12-mo target
+8.4%
vs. last · 27 analysts
At a Glance
$295.7B
market cap (USD)
exchangeNYQ
sectorHealthcare
industryDrug Manufacturers - General
market cap$295.7B
websitemerck.com
The Briefs
live, polled every 60 seconds · Alpaca / Benzinga
No recent headlines for MRK in the last 7 days.
Word on the Street
StockTwits public feed · self-tagged bull/bear
No recent StockTwits posts for MRK.
Indicators That Mention MRK
1 of our 596 catalog map to MRK
SP-3415
MRK TRI Chemical Releases
Annual chemical releases from Merck US plants. Pharma + vaccine production.
50%
50%
50%
50%
50%
50%
◐Too new to retest
r=0.00
Standard Poorly Disclaimer
We tested 297 indicators against four horizons. By chance alone, ~59 of these correlations should look "significant." Walk-forward out-of-sample is the only thing we trust. This one too new to retest.Other Players in the Pipeline
Healthcare · by market cap · 7-day move